| # | % | |||||
|---|---|---|---|---|---|---|
| 1 | SPDR S&P BIOTECH ETF | 1,600,000 | 106,064,000 | 17.27% | Put | |
| 2 | ISHARES TR | 200,000 | 57,892,000 | 9.43% | Put | |
| 3 | MERCK & CO INC | 300,000 | 18,723,000 | 3.05% | ||
| 4 | TEVA PHARMACEUTICAL INDS LTD | 402,000 | 18,496,000 | 3.01% | ||
| 5 | SAREPTA THERAPEUTICS INC | 263,047 | 16,154,000 | 2.63% | ||
| 6 | ALLERGAN PLC | 70,000 | 16,122,000 | 2.62% | ||
| 7 | LILLY ELI & CO | 200,000 | 16,052,000 | 2.61% | ||
| 8 | BIOGEN INC | 50,000 | 15,652,000 | 2.55% | ||
| 9 | COLUCID PHARMACEUTICALS INC COM | 400,000 | 15,260,000 | 2.48% | ||
| 10 | PFIZER INC | 426,612 | 14,449,000 | 2.35% | ||
| 11 | ITURAN LOCATION AND CONTROL LTD | 456,668 | 12,083,000 | 1.97% | ||
| 12 | CELGENE CORP | 110,000 | 11,498,000 | 1.87% | ||
| 13 | AMGEN INC | 65,900 | 10,993,000 | 1.79% | ||
| 14 | HORIZON PHARMA PLC | 535,000 | 9,700,000 | 1.58% | ||
| 15 | GILEAD SCIENCES INC | 112,700 | 8,917,000 | 1.45% | ||
| 16 | ALEXION PHARMACEUTIC | 70,000 | 8,578,000 | 1.40% | ||
| 17 | MYLAN N V | 200,000 | 7,624,000 | 1.24% | ||
| 18 | BIOMARIN PHARMACEUTICAL INC CALL | 80,000 | 7,402,000 | 1.21% | Call | |
| 19 | SAGE THERAPEUTICS | 159,500 | 7,345,000 | 1.20% | ||
| 20 | AMICUS THERAPEUTICS INC | 905,000 | 6,697,000 | 1.09% | ||
| 21 | ASTRAZENECA PLC | 200,000 | 6,572,000 | 1.07% | ||
| 22 | ACHAOGEN INC COM | 1,300,313 | 6,228,000 | 1.01% | ||
| 23 | ARRAY BIOPHARMA INC COM | 900,000 | 6,075,000 | 0.99% | ||
| 24 | NICE LTD | 86,040 | 5,760,000 | 0.94% | ||
| 25 | CORVUS PHARMACEUTICALS INC COM | 325,053 | 5,347,000 | 0.87% | ||
| 26 | Ascendis Pharma | 263,500 | 5,296,000 | 0.86% | ||
| 27 | GLYCOMIMETICS INC | 718,080 | 5,134,000 | 0.84% | ||
| 28 | TESARO INC | 50,000 | 5,012,000 | 0.82% | ||
| 29 | EIGER BIOPHARMACEUTICALS INC | 373,568 | 5,002,000 | 0.81% | ||
| 30 | NEURODERM LTD | 253,513 | 4,687,000 | 0.76% | ||
| 31 | ADAMAS PHARMACEUTICALS INC | 270,000 | 4,431,000 | 0.72% | ||
| 32 | CHARTER COMM | 16,165 | 4,364,000 | 0.71% | ||
| 33 | RETROPHIN INC COM | 190,000 | 4,252,000 | 0.69% | ||
| 34 | AVEXIS INC COM | 100,000 | 4,121,000 | 0.67% | ||
| 35 | GW PHARMACEUTICALS PLC | 31,000 | 4,115,000 | 0.67% | ||
| 36 | SELECTA BIOSCIENCES INC | 284,652 | 3,989,000 | 0.65% | ||
| 37 | ACADIA PHARMACEUTICALS INC COM | 125,000 | 3,976,000 | 0.65% | ||
| 38 | Clearside Biomedical Inc | 226,100 | 3,923,000 | 0.64% | ||
| 39 | MACROGENICS INC | 130,000 | 3,888,000 | 0.63% | ||
| 40 | ALPHABET INC | 4,818 | 3,874,000 | 0.63% | ||
| 41 | INOTEK PHARMACEUTICALS CORP | 401,764 | 3,809,000 | 0.62% | ||
| 42 | FIDELITY NATL INFORMATION SV | 48,160 | 3,710,000 | 0.60% | ||
| 43 | ALDER BIOPHARMACEUTICALS INC | 112,500 | 3,687,000 | 0.60% | ||
| 44 | UNION PAC CORP | 37,275 | 3,635,000 | 0.59% | ||
| 45 | VISA INC | 42,791 | 3,539,000 | 0.58% | ||
| 46 | ORBOTECH LTD | 116,102 | 3,438,000 | 0.56% | ||
| 47 | Foamix Pharmaceuticals Ltd. | 342,000 | 3,167,000 | 0.52% | ||
| 48 | AIR PRODS & CHEMS INC | 21,045 | 3,164,000 | 0.52% | ||
| 49 | FIVE PRIME THERAPEUTICS INC | 60,000 | 3,149,000 | 0.51% | ||
| 50 | GENOCEA BIOSCIENCES INC | 609,271 | 3,119,000 | 0.51% |
Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0001178913-16-006879, filed 2016.11.14).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
